Cargando…

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel proposed concept that is being recognized worldwide. Both chronic hepatitis B (CHB) and MAFLD have been independently attributed to an increased risk of disease development to cirrhosis. However, it is still unclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qing-Xia, Xue, Jiao, Shi, Mei-Jie, Xie, Yu-Bao, Xiao, Huan-Ming, Li, Sheng, Lin, Ming, Chi, Xiao-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356614/ https://www.ncbi.nlm.nih.gov/pubmed/35942038 http://dx.doi.org/10.2147/DMSO.S369824

Ejemplares similares

Impact of Metabolic Dysfunction Associated Fatty Liver Disease on the Prognosis of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Based on Propensity Score Matching Analysis
por: Xue, Jiao, et al.
Publicado: (2022)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019)

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
por: Wang, Xiaolin, et al.
Publicado: (2022)

Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients
por: He, Xia, et al.
Publicado: (2021)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
por: Chen, Xu, et al.
Publicado: (2021)

Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
por: Li, Hai, et al.
Publicado: (2016)

Endogenous carbon monoxide downregulates hepatic cystathionine-γ-lyase in rats with liver cirrhosis
por: GUO, SHI-BIN, et al.
Publicado: (2015)

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
por: Bazwinsky-Wutschke, Ivonne, et al.
Publicado: (2019)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis
por: Luo, Ming, et al.
Publicado: (2020)

The gut–liver axis in immune remodeling of hepatic cirrhosis
por: Guan, Huayu, et al.
Publicado: (2022)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
por: Cheng, Yu-Ming, et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis
por: Paternostro, Rafael, et al.
Publicado: (2016)

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
por: Xiao, Yuji, et al.
Publicado: (2023)

Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients
por: Hatami, Behzad, et al.
Publicado: (2017)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma
por: Chen, Vincent L., et al.
Publicado: (2020)

Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
por: Huang, Jee-Fu, et al.
Publicado: (2023)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease
por: Hu, Na, et al.
Publicado: (2023)

Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection
por: Wang, Ming-Fang, et al.
Publicado: (2021)

Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
por: Ding, Yuping, et al.
Publicado: (2023)

Cardiovascular dysfunction in patients with liver cirrhosis
por: Fede, Giuseppe, et al.
Publicado: (2015)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
por: Zhou, Xiao-Dong, et al.
Publicado: (2022)

Autonomic dysfunction is common in liver cirrhosis and is associated with cardiac dysfunction and mortality: prospective observational study
por: Pimentel, Carolina Frade Magalhães Girardin, et al.
Publicado: (2021)

Comparison of Electrocardiogram and QT Interval between Viral Hepatitis Cirrhosis and Alcoholic Cirrhosis
por: Lu, Li-Hong, et al.
Publicado: (2022)

Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy
por: Khan, Abidullah, et al.
Publicado: (2016)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Liver Lobe Based Multi-Echo Gradient Recalled Echo T(2)*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis
por: Wang, Dan, et al.
Publicado: (2016)

No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV
por: Nakamura, Masato, et al.
Publicado: (2013)

Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis
por: Schroeder, Matthew, et al.
Publicado: (2023)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
por: Huang, Shang-Chin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ccnude6vpsh4luqdfhnieqs2jh